16 October 2019
When mistakes happen in healthcare there can be terrible consequences. This session will discuss the investigation of errors in a no blame manner and ways to support staff when things go wrong.
|Presenter:||Dr Nolan McDonnell, Clinical Associate Professor, King Edward Memorial Hospital.|
This session will present the role a Milk Bank plays and the processes taken to establish the service.
|Presenter:||Richard Brown, Integration Manager Business Growth and Innovation, Australian Red Cross Blood Service.|
13 February 2019 01:30pm - 02:30pm Australia/Sydney
This session will discuss the considerations to be made when transfusing neonates, particularly for those needing intensive care management.
|Presenter:||Dr Bryony Ross, Staff Specialist Haematologist Pathology North, John Hunter Children's Hospital, Calvary Mater Newcastle.|
17 October 2018 01:30 - 02:30pm - Australia/Sydney
Direct oral anticoagulants (DOACs) are indicated for the prevention of systemic embolism in selected patients with non-valvular atrial fibrillation and for the prevention and /or treatment of venous thromboembolism. Guidance on when and how to reverse DOACs is discussed.
|Presenter:||Dr Simon McRae, Chairman, Australian Haemophilia Centre Directors Organisation, Consultant Haematologist SA Pathology, Royal Adelaide Hospital.|
12 September 2018 01:30 - 02:30pm - Australia/Sydney
SHOT is the United Kingdom's independent, professionally-led haemovigilance scheme. Since 1996 SHOT has been collecting and analysing anonymised information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood and blood components in the United Kingdom. Where risks and problems are identified, SHOT produces recommendations to improve patient safety.
|Presenter:||Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion Scheme NHSBT, UK|
This session will explore both the early treatments for haemophilia and new technologies being implemented and considered to advance treatment.
|Presenter:||Dr Kobie Von Wielligh, Haemostasis Fellow, Central Adelaide Local Health Network|
Transfusion Update Conference 2017: Day 1 Clinical - Thursday 27 April 2017
Presenter: Dr Lacey Johnson, Principal Research Fellow, Australian Red Cross Blood Service
10 May 2017 01:30pm - 02:30pm - Australia/Sydney
How I get the best out of a platelet transfusion.
|Presenter:||Dr Richard Kaufman, Associate Professor of Pathology, Harvard Medical School and Medical Director of Adult Transfusion Medicine Service, Brigham and Women's Hospital, United States of America.|
Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, over three million doses of anti-D have been given to Rh negative women.
The program provides plasma collected from blood donors with anti-D for production of anti-D immunoglobulin for treatment of RhD negative women with babies at risk of haemolytic disease of the fetus and newborn (HDFN).
The following two presentations commemorate 50 years of the Anti-D Program and look at the prevention of Rh HDFN.
|Presenters:||Jessie Wallis, RhD Program Coordinator, South Australia, Australian Red Cross Blood Service.|
|Dr Amanda Thomson, Haematologist/Transfusion Medicine Specialist, Australian Red Cross Blood Service.|